This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shawn Black and Patent Innovation in Myasthenia Gravis Treatment
Introduction
Shawn Black is an inventor associated with Spring House, Pennsylvania, and Momenta Pharmaceuticals, Inc. His patent work includes an invention concerning antibodies that target FcRn and methods for treating myasthenia gravis.
Latest Patents
Black is listed on 1 patent: “Anti-FcRn Antibodies and Methods for Treating Myasthenia Gravis.” The patent focuses on antibody-based approaches and methods related to treatment of the autoimmune disorder.
Career Highlights
Black’s recorded patent activity connects his work with Momenta Pharmaceuticals, Inc. and research into therapeutic approaches for myasthenia gravis.
Collaborations
Black’s listed coworkers include Sindhu Ramchandren and Hong Sun.
Conclusion
Shawn Black’s patent record highlights his contribution to antibody-based research and potential treatment approaches for myasthenia gravis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile